El interés en corto de iShares Ethereum Trust - iShares Ethereum Trust ETF da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de iShares Ethereum Trust - iShares Ethereum Trust ETF. Los datos de interés en corto se actualizan cada dos semanas.

iShares Ethereum Trust - iShares Ethereum Trust ETF (NASDAQ:ETHA) Bolsa, Informe de interés en corto

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

Markets

ETFs

$BTC

$ETH

ETHA

ETHE

Fidelity Ethereum Fund Fidelity Ethereum Fund

FETH

Jamie Dimon, el CEO del gigante bancario JPMorgan, ha reconocido la importancia de las criptomonedas basadas en contratos inteligentes, en marcado contraste con su postura sobre Bitcoin (CRYPTO: BTC).

Jamie Dimon reconoce el valor de las criptomonedas con contratos inteligentes, sigue rechazando Bitcoin

ARK 21Shares Bitcoin ETF ARK 21Shares Bitcoin ETF

ARKB

Fidelity Wise Origin Bitcoin Fund Fidelity Wise Origin Bitcoin Fund

FBTC

GBTC

IBIT

El gigante de la banca de inversión Goldman Sachs (NYSE:GS) adquirió más acciones de los fondos cotizados en bolsa (ETF) de Bitcoin (CRYPTO: BTC) y Ethereum (CRYPTO: 

Goldman Sachs apuesta fuerte por Bitcoin y Ethereum: sus tenencias superan los 2.000M$

General

$DOGE

El gestor de fondos índice de criptomonedas Bitwise Asset Management presentó este miércoles una solicitud para un fondo cotizado en bolsa (ETF) de Dogecoin (CRYPTO: DOGE), lo que llevó a los analistas a prever grandes rendimientos para la criptomoneda inspirada en memes.

¿Dogecoin (DOGE) alcanzará los 15$? ETF de Bitwise podría disparar la criptomoneda meme

iShares Ethereum Trust - iShares Ethereum Trust ETF

Ethan Allen Interiors Inc

FTRE

Fortrea Board Adopts Limited-Duration Stockholder Rights Plan, Effective Immediately; Set To Expire June 10, 2026

Producer prices snapped back in May after an April decline, but the rebound fell short of sparking inflation concerns, suggesting tariffs and supply frictions have yet to bleed <a href="https://www.benzinga.com/news/econ-s">broadly into the economy.</a>
The Producer Price Index rose 2.6% on a year-over-year basis, up from April's upwardly revised 2.5%, according to Thursday's report from the Bureau of Labor Statistics. 
On a monthly basis, the PPI advanced 0.1%, reversing April's upwardly revised 0.2% decline, and below the 0.2% expected. 
Core PPI, which strips out food and energy prices and is a key indicator of underlying inflation pressures, eased to 3% annually from April's 3.2%. This marks the lowest level since August 2024. On a monthly basis, core PPI inched 0.1%, rebounding from a 0.2% decline in the prior month, below than expected 0.3%. 
Thursday's producer data arrived one day after a softer-than-expected consumer inflation reading. The Consumer Price Index climbed 2.4% year-over-year in May, up slightly from April's 2.3%, but below the anticipated 2.5% increase. 
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th>Producer Inflation</th>
<th>May 2025</th>
<th>April 2025</th>
<th>Expected</th>
</tr>
</thead>
<tbody>
<tr>
<td>PPI YoY</td>
<td>2.6%</td>
<td>2.5%</td>
<td>2.6%</td>
</tr>
<tr>
<td>PPI MoM</td>
<td>0.1%</td>
<td>-0.2%</td>
<td>0.2%</td>
</tr>
<tr>
<td>Core PPI YoY</td>
<td>3.0%</td>
<td>3.2%</td>
<td>3.1%</td>
</tr>
<tr>
<td>Core PPI MoM</td>
<td>0.1%</td>
<td>-0.2%</td>
<td>0.3%</td>
</tr>
</tbody>
</table>
</figure>
In a separate release Thursday, the Department of Labor reported that initial jobless claims rose to 248,000 for the week ending June 7, above forecasts for 240,000. Continuing claims surged to 1.956 million, the highest level since November 2021 and above consensus projections of 1.91 million.
The increase in unemployment filings is further evidence of a softening labor market, potentially giving the Federal Reserve additional room to resume the pace of interest rate cuts.
Fed futures currently price in a near-certainty of a first rate cut by October. Traders are assigning roughly 35 basis points of total easing by year-end, implying at least one full 25-basis-point cut and a high probability of a second.
This is a developing story&#8230;
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/45899819/us-stocks-likely-to-open-lower-look-through-near-term-noise-be-deliberate-about-the-kinds-of-risk-youre-taking-leverage-ai-say-experts">US Stocks Likely To Open Lower: &#8216;Look Through Near-Term Noise, Be Deliberate About The Kinds Of Risk You&#8217;re Taking, Leverage AI,&#8217; Say Experts</a></li>
</ul>
Photo: Shutterstock

Macro Economic Events

Econ #s

Economics

Federal Reserve

Producer Inflation Rises Less Than Forecasts In May, Jobless Claims Signal Labor Market Cracks

WIIM

INTS

Intensity Therapeutics shares are trading lower after the company announced it priced its $2 million public offering of 6.675 million shares at $0.30 per share

Stephens &amp; Co. analyst Jim Salera maintains Darden Restaurants (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) with a Equal-Weight and raises the price target from $178 to $200.

Price Target

Analyst Ratings

Stephens & Co. Maintains Equal-Weight on Darden Restaurants, Raises Price Target to $200

RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) will release earnings results for the first quarter, after the closing <a href="https://www.benzinga.com/quote/rh/earnings">bell on Thursday, June 12</a>.
Analysts expect the Corte Madera, California-based company to report quarterly loss at 7 cents per share, versus a year-ago loss of 40 cents per share. RH projects to report quarterly revenue at $818.57 million, compared to $726.96 million a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On May 20, RH named Lisa Chi as President and Co-Chief Merchandising &amp; Creative Officer.
RH shares fell 5.5% to close at $178.98 on Wednesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/RH/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Wells Fargo analyst Zachary Fadem maintained an Overweight rating and cut the price target from $300 to $250 on June 9, 2025. This analyst has an accuracy rate of 84%.</li>
<li>UBS analyst Michael Lasser maintained a Neutral rating and cut the price target from $235 to $215 on June 5, 2025. This analyst has an accuracy rate of 79%.</li>
<li>Goldman Sachs analyst Kate McShane maintained a Neutral rating and cut the price target from $276 to $194 on May 5, 2025. This analyst has an accuracy rate of 67%.</li>
<li>JP Morgan analyst Christopher Horvers maintained an Overweight rating and slashed the price target from $510 to $250 on April 14, 2025. This analyst has an accuracy rate of 71%.</li>
<li>Morgan Stanley analyst Simeon Gutman maintained an Overweight rating and cut the price target from $530 to $300 on April 3, 2025. This analyst has an accuracy rate of 66%.</li>
</ul>
Considering buying RH stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/RH/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="583" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12041119/image-179-1024x583.png" alt="" class="wp-image-947229" style="width:592px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12041119/image-179-1024x583.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12041119/image-179-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12041119/image-179-768x437.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12041119/image-179.png 1112w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45882911/top-2-consumer-stocks-that-may-plunge-in-june">Top 2 Consumer Stocks That May Plunge In June</a> </li>
</ul>
Photo via Shutterstock

Earnings

Trading Ideas

RH Likely To Report Narrower Q1 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

As of June 12, 2025, two stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a> 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Caseys General Stores Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CASY#NASDAQ">CASY</a>)</h3>
<ul class="wp-block-list">
<li>On June 9, Caseys General Stores reported better-than-expected fourth-quarter financial results and increased its quarterly dividend. "Inside same-store sales outperformed the industry, up 2.6%, or 7.1% on a two-year stack basis, led by strong performance in hot sandwiches and bakery as well as alcoholic and non-alcoholic beverages. Our fuel team grew market share and produced a healthy margin, as fuel gross profit increased 10.7% from the prior year," said Darren Rebelez, president and CEO of Casey's General Stores. The company's stock jumped around 14% over the past month and has a 52-week high of $509.08.</li>
<li>RSI Value: 74.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>CASY Price Action: Shares of Caseys General Stores gained 1.9% to close at $499.53 on Wednesday.</li>
<li>Edge Stock Ratings: 89.51 Momentum score with Value at 53.81. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/CASY"><img loading="lazy" decoding="async" width="436" height="197" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12072712/image-186.png" alt="" class="wp-image-947474" style="width:308px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12072712/image-186.png 436w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12072712/image-186-300x136.png 300w" sizes="(max-width: 436px) 100vw, 436px" /></a></figure>
<h3 class="wp-block-heading">elf Beauty Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>)</h3>
<ul class="wp-block-list">
<li>On May 28, e.l.f. Beauty reported better-than-expected quarterly results and announced it will acquire Rhode. "In this dynamic environment, we continue to deliver industry-leading results. In Fiscal 2025, we grew net sales 28%, gained 190 basis points of market share in the U.S. and continued our international expansion strategy," said Tarang Amin, chairman and CEO of e.l.f. Beauty. The company's stock gained around 68% over the past month and <a href="https://www.benzinga.com/quote/ELF">has a 52-week high</a> of $219.77.</li>
<li>RSI Value: 88.1</li>
<li>ELF Price Action: Shares of elf Beauty gained 5.6% to close at $124.52 on Wednesday.</li>
</ul>
BZ Edge Rankings: Find out where other stocks stand—<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">explore the full comparison now</a>.
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45882911/top-2-consumer-stocks-that-may-plunge-in-june">Top 2 Consumer Stocks That May Plunge In June</a> </li>
</ul>
Photo via Shutterstock

Short Ideas

Pre-Market Outlook

CASY

Top 2 Defensive Stocks That May Keep You Up At Night In Q2

U.S. stock futures were lower this morning, with the Dow futures falling more than 250 points on Thursday.
Shares of Oxford Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXM#NYSE">OXM</a>) fell sharply in today's pre-market trading as the company reported in-line earnings for the first quarter and issued second-quarter earnings guidance below estimates. Also, the company <a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/45877826/oxford-industries-likely-to-report-lower-q1-earnings-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">lowered its FY25 guidance.</a>
Oxford Industries posted adjusted EPS of $1.82, in-line with estimates. The company's quarterly sales came in at $392.86 million versus expectations of $384.77 million.
Oxford Industries shares dipped 10.1% to $44.99 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul class="wp-block-list">
<li>Tonix Pharmaceuticals Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNXP#NASDAQ">TNXP</a>) dipped 17% to $31.32 in pre-market trading. Tonix Pharmaceuticals may sell up to $150 million in common stock.</li>
<li>GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) fell 12.4% to $24.97 in pre-market trading after the company announced a $1.75 billion proposed private offering of convertible senior notes.</li>
<li>Karooooo Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KARO#NASDAQ">KARO</a>) dipped 11.1% to $52.94 in pre-market trading.</li>
<li>Yiren Digital Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YRD#NYSE">YRD</a>) declined 10.1% to $6.69 in pre-market trading.</li>
<li>QuantaSing Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSG#NASDAQ">QSG</a>) fell 9.9% to $10.87 in pre-market trading.</li>
<li>DeFi Development Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DFDV#NASDAQ">DFDV</a>) dipped 8.6% to $24.00 in pre-market trading.</li>
<li>The Boeing Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) fell 7.4% to $198.10 in pre-market trading. An Air India Boeing 787-8 Dreamliner by Boeing crashed on Thursday near the India's Ahmedabad airport, with 242 passengers on board. The flight was en route to London Gatwick from Ahmedabad.</li>
<li>GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) fell 4.4% to $234.57 in pre-market trading.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45882911/top-2-consumer-stocks-that-may-plunge-in-june">Top 2 Consumer Stocks That May Plunge In June</a> </li>
</ul>
Photo via Shutterstock

Movers

DFDV

KARO

TNXP

Oxford Industries, GameStop, Boeing And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Peer Reviewed Clinical Study for H3.1 Biomarker Published in Critical Care
HENDERSON, Nev., June 12, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNRX#NYSE">VNRX</a>) ("Volition"), a multi-national epigenetics company, today announced <a href="https://ccforum.biomedcentral.com/articles/10.1186/s13054-025-05415-6#citeas">the publication of a new clinical manuscript</a>&nbsp;suggesting that the Nu.Q&#xAE; H3.1 biomarker has the potential to inform clinical care in critically-ill Intensive Care Unit (ICU) patients in the assessment of sepsis, organ failure and subphenotypes.
About the Study This study aimed to evaluate H3.1 nucleosomes in critical illness, assessing their relationship with sepsis, organ failure, inflammatory subphenotypes and outcomes.
The MARS cohort was used, comprising of consecutive Intensive Care Unit patients (n=1713 patients), with plasma samples collected on days 0, 2 and 4 (n=3671 plasma samples).
H3.1 nucleosome concentrations were measured using the Nu.Q&#xAE; NETs Immunoassay at baseline and longitudinally.
The relationship between H3.1 nucleosome concentrations and clinical outcomes was investigated.

VNRX

VolitionRx Announces Publication Of New Clinical Manuscript Suggesting That Nu.Q H3.1 Biomarker Has Potential To Inform Clinical Care In Critically-Ill ICU Patients In Assessment Of Sepsis, Organ Failure And Subphenotypes

Contracts

Eaton Awarded Multiple Contracts Valued At $25M For Hartsfield-Jackson Atlanta International Airport

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Baird analyst David Manthey initiated coverage on QXO, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QXO#NYSE">QXO</a>) with an Outperform rating and announced a price target of $32. QXO shares closed at $19.95 on Wednesday. <a href="https://www.benzinga.com/quote/qxo/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler analyst Yasmeen Rahimi initiated coverage on Tvardi Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVRD#NASDAQ">TVRD</a>) with an Overweight rating and announced a price target of $78. Tvardi Therapeutics shares closed at $26.22 on Wednesday. <a href="https://www.benzinga.com/quote/tvrd/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Roth Capital analyst Joe Reagor initiated coverage on AngloGold Ashanti plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AU#NYSE">AU</a>) with a Buy rating and announced a price target of $52. Anglogold Ashanti shares closed at $45.87 on Wednesday. <a href="https://www.benzinga.com/quote/AU/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Texas Capital Securities analyst David Bain initiated coverage on Genius Sports Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GENI#NYSE">GENI</a>) with a Buy rating and announced a price target of $14. Genius Sports shares closed at $9.66 on Tuesday. <a href="https://www.benzinga.com/quote/GENI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keybanc analyst David Tarantino initiated coverage on Modine Manufacturing Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOD#NYSE">MOD</a>) with an Overweight rating and announced a price target of $125. Modine Manufacturing shares closed at $94.15 on Wednesday. <a href="https://www.benzinga.com/quote/MOD/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying MOD stock? Here&#8217;s what analysts think: 
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45882911/top-2-consumer-stocks-that-may-plunge-in-june">Top 2 Consumer Stocks That May Plunge In June</a> </li>
</ul>
Photo via Shutterstock

Initiation

GENI

TVRD

This Modine Manufacturing Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Tempus AI To Collaborate With The Abrams Research Center On Neurogenomics At Northwestern University Feinberg School Of Medicine To Harness AI For Discovery in Alzheimer's Research

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHPH#NASDAQ">SHPH</a>) ("Shuttle Pharma" or the "Company"), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), announces that its Board of Directors have approved a proposed reverse stock split of its common stock at a ratio of 25-for-1. The proposed action remains subject to approval by Nasdaq and, if approved, the Company will issue a subsequent announcement disclosing the effective date.
At the effective time of the reverse stock split, every 25 shares of the Company's issued and outstanding common stock will be automatically reclassified and combined into 1 share of common stock. This will reduce the number of issued and outstanding shares of common stock from 26,210,037 shares to approximately 1,048,401 shares, without giving effect to rounding. The split will also apply to Company common stock issuable upon the exercise of the Company's outstanding RSU grants and warrants. No fractional shares will be issued; instead, any fractional entitlements will be rounded up to the next highest whole number at the participant level.
The reverse stock split is part of Shuttle's strategic plan to maintain compliance with Nasdaq's continued listing requirements, while also strengthening the Company's long-term capital structure.

Stock Split

SHPH

Shuttle Pharma Board Approves Proposed Reverse Stock Split Of Common Stock At Ratio Of 25-For-1

SOAR

Volato Group shares are trading higher after the company announced it signed a non-binidng term sheet to acquire M2i Global.

BLIN

Bridgeline Digital Renews Engagement With Global Water Technology Provider To Optimize Online Presence Of One Of Its Flagship Brands

Micron Plans To Invest Approximately $200B In Semiconductor Manufacturing And R&D In Idaho, New York And Virginia; Will Build A Memory Manufacturing Fab In Idaho And Expand Virginia Fab

Management

STRL

Sterling Infrastructure Appoints Nicholas Grindstaff As CFO, Effective July 10, 2025

ALLE

Allegion To Acquire ELATEC For €330M On A Cash-Free And Debt-Free Basis

Guidance

SAGT

Sagtec Global Projects FY25 Net Income To Be ~$2.56M Vs $1.60M Last Year, Up 60% Yoy

Needham analyst Mike Matson downgrades Conmed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNMD#NYSE">CNMD</a>) from Buy to Hold and maintains the price target from $61 to $61.

Downgrades

CNMD

Needham Downgrades Conmed to Hold, Maintains Price Target to $61

Buybacks

IMAX

IMAX Announces $100M Increase To Its Current Share Repurchase Program

Press Releases

BlackRock's ETHA Debuts on Nasdaq

Comments

iShares Ethereum Trust - iShares Ethereum Trust ETF

Interés en corto

iShares Ethereum Trust - iShares Ethereum Trust ETF (NASDAQ:ETHA) Bolsa, Informe de interés en corto

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL